333 Bay St, Suite 2400, Bay Adelaide Ctr, Box 20, Toronto, ON
Year called to bar: 2002
Aaron Stefan is a Partner in Fasken’s Banking and Finance group with over 20 years of experience advising on corporate/commercial transactions. He regularly advises on syndicated and non-syndicated secured and unsecured credit facilities, acquisition financings, receivables purchases, asset-based lending and private lending. Aaron acts for financial institutions as well as private and public companies in a wide range of industries including energy, mining, manufacturing, agribusiness, transportation, real estate, technology and professional services. His legal and business acumen is trusted in connection with matters that are cross-border, multi-currency, senior/subordinated and multi-jurisdictional in nature.
On October 21, 2015, Concordia Healthcare Corp. (“Concordia”), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, acquired UK-based Amdipharm Mercury Limited (“AMCo”) from Cinven Ltd, a leading European private equity firm, for approximately US$3.3 billion (the “Acquisition”) paid through a combination of cash and the issuance of 8.49 million common shares of Concordia.
On April 21, 2015, Concordia Healthcare Corp. (Concordia), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, acquired 18 products from Covis Pharma S.à.r.l and Covis Injectables, S.à.r.l (collectively, Covis). The purchase price of US$1.2 billion was paid in cash at closing.
